SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

RBC Capital Maintains Outperform on Teladoc Health, Raises Price Target to $235

RBC Capital maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $200 to $235.

Benzinga · -
RBC Capital maintains Teladoc Health (NYSE: TDOC) with a Outperform and raises the price target from $200 to $235.